| Product NDC: | 25021-204 |
| Proprietary Name: | Vinorelbine |
| Non Proprietary Name: | Vinorelbine |
| Active Ingredient(s): | 10 mg/mL & nbsp; Vinorelbine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-204 |
| Labeler Name: | Sagent Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078011 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090914 |
| Package NDC: | 25021-204-05 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (25021-204-05) > 5 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 25021-204-05 |
| Proprietary Name | Vinorelbine |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (25021-204-05) > 5 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 25021-204 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Vinorelbine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090914 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceutical, Inc. |
| Substance Name | VINORELBINE TARTRATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient] |